Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • Mar 15, 2017
    Nevada Senate Bill Requires Makers of Diabetes Drugs To Report Costs and Provide Reimbursements
  • Mar 14, 2017
    Benchmarking Survey Details Ad Promotion Metrics
  • Mar 12, 2017
    Gottlieb Nominated To Head FDA as Commissioner of Food and Drugs
  • Mar 10, 2017
    Trade Groups Oppose Oregon Bill Requiring Drug Makers To Disclose Wholesale Price in Ads
  • Mar 9, 2017
    Goodlatte Asks Bar Associations To Amend Rules on Ads for Drug Injury Lawsuits
  • Mar 9, 2017
    OPDP Research Examines Presentation of Risk Information in Direct-to-Consumer TV Ads
  • Mar 9, 2017
    NAD Recommends Dietary Supplement Maker Modify or Discontinue Challenged Claims
  • Mar 2, 2017
    Maryland Bill Calls for Drug Financial Reporting
  • Mar 1, 2017
    Vermont Senate Considers Resolution To ‘Rein in’ Prescription Drug Promotion
  • Mar 1, 2017
    Promotional Advisory Times Could Get Longer
  • More

Good Clinical Practice

  • Sep 18, 2017
    How To Acknowledge Nonauthor Contributions To Journal Articles?
  • Sep 18, 2017
    NIH Revises Certificates of Confidentiality Policy
  • Sep 18, 2017
    Review Finds ‘Spin’ Prevalent in Journal Articles
  • Sep 15, 2017
    NIH Releases Tools To Aid Researchers in Implementing Recent Trial Policy Changes
  • Sep 14, 2017
    Prospective Trial Registration Reduces Outcome Discrepancies, Finnish Study Finds
  • Sep 13, 2017
    More Communication Needed on New Trial Designs
  • Sep 12, 2017
    FDA Wants Ethnic and Racial Demographic Data Captured in Two Distinct Categories
  • Sep 9, 2017
    Mass. Senate Bill Calls on FDA to Clarify Inducement of Cancer Trial Subjects
  • Sep 5, 2017
    FDA Finalizes Guidance on Use of Real-World Evidence When Making Regulatory Decisions About Devices
  • Aug 31, 2017
    FDA Updates E-submission Standards
  • More

U.S. Food Labeling

  • Jun 30,2011
    Federal Judge Dismisses Suit Against General Mills
  • Jun 30,2011
    Industry Group Files Petition Challenging FTC's Substantiation Requirements for Claims
  • Jun 30,2011
    House Appropriations Bill Blocks FDA Approval of Genetically Engineered Salmon
  • Jun 30,2011
    Bakery Gets Warning Letter for Undercounting Fats
  • Jun 30,2011
    Fiji's Green Is Clean, Says California Court
  • Jun 30,2011
    Product Recalls
  • May 31,2011
    Sugar Industry Sues To Block HFCS Rebranding
  • May 31,2011
    FDA Warns Tea Companies for Making Drug Claims
  • May 31,2011
    Product Recalls
  • May 31,2011
    Interagency Working Group Unveils Principles for Marketing Food Products to Kids
  • More

FDA Regulation & Enforcement

  • Feb 11, 2020
    FDA Issues Draft Guidance on Biosimilar Promotion
  • Feb 10, 2020
    FDA Warning Letter Citing Purell Hand Sanitizer Claims Prompts Consumer Class Action Suits
  • Feb 5, 2020
    EHR Developer To Pay $145 Million To Settle Allegations of Rigging Software To Boost Opioid Sales
  • Feb 3, 2020
    California Court Requires J&J To Pay $344 Million Over ‘False and Deceptive’ Marketing of Pelvic Mesh Products
  • Jan 31, 2020
    House Bill Would Extend FDA’s Administrative Destruction Authority to Devices, Combination Products
  • Jan 30, 2020
    New Biotech Regulatory Website Now Up and Running
  • Jan 30, 2020
    Senators Press FDA To Move Against ‘Misuse' of Dairy Terms on Nondairy Product Labeling
  • Jan 30, 2020
    AMS Extends Comment Deadline on Draft Instructions for Validating Methods To Detect Genetic Material for Labeling
  • Jan 29, 2020
    OPDP Announces Research Projects on Product Endorsements and Proprietary Names
  • Jan 28, 2020
    District Court in Boston Hands Down Sentences — Including Prison Time — to Seven Insys Executives
  • More

Medical Devices

  • Mar 10, 2014
    Device Company Sentenced After Pleading Guilty to Charge of Withholding Unfavorable Trial Results
  • Feb 28, 2014
    FDA Issues Final Rule on Pediatric Subpopulation Information Required for PMAs, Other Applications
  • Feb 26, 2014
    FDA To Update 1997 Guidance on 510(k) Modifications
  • Feb 25, 2014
    District Court Dismisses Challenge to OIG Special Fraud Alert on PODs Due to Lack of Standing
  • Feb 19, 2014
    Final Rule Mandates Electronic MDRs by August 2015
  • Feb 10, 2014
    FDA Guidance Outlines Information Required in Annual Reports on Approved PMA Devices
  • Feb 7, 2014
    CDRH Sets IDE Process Improvement as Strategic Priority
  • Feb 4, 2014
    HHS OIG Work Plan Includes Projects on Defective Devices, Data Security, Possible Program Savings
  • Jan 31, 2014
    Competitive Bidding Is Limiting Medicare Patients’ Access to Diabetes Supplies, Association Charges
  • Jan 27, 2014
    FDA Works on Evaluating Sex Effects in Device Post-approval Studies
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.